Hyderabad Telangana, India

Balusu Rajababu


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Balusu Rajababu in Pharmaceutical Patents

Introduction

Balusu Rajababu is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on crystalline forms of Nelfinavir mesylate. His research has the potential to enhance the efficacy and safety of this important medication.

Latest Patents

Rajababu holds a patent for the crystalline forms of Nelfinavir mesylate. This invention provides novel crystalline forms, specifically Form-A, Form-B, Form-C, and Form-D, along with the process for their preparation. Notably, this process does not require any special equipment, such as a spray drier, and avoids the use of highly flammable solvents like ethers. The crystalline forms can be tailored by selecting the appropriate ante solvent and conditions for the process.

Career Highlights

Balusu Rajababu is currently associated with Mylan Laboratories Limited, a leading global pharmaceutical company. His work at Mylan has allowed him to focus on developing innovative solutions that address critical health challenges. His expertise in pharmaceutical formulations has been instrumental in advancing the company's product offerings.

Collaborations

Rajababu has collaborated with several talented individuals in his field, including Chava Satyanarayana and Vasireddy Umamaheswara-Rao. These collaborations have fostered a productive environment for innovation and have contributed to the successful development of new pharmaceutical products.

Conclusion

Balusu Rajababu's contributions to the field of pharmaceuticals, particularly through his patent on crystalline forms of Nelfinavir mesylate, highlight his innovative spirit and dedication to improving healthcare solutions. His work continues to inspire advancements in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…